IP Library Granted Patent US 11,981,936
Granted Patent B1
US 11,981,936 · App. 18/478,512 · Granted May 14, 2024

TelA variants, compositions, and methods

Inventors: Shuang-Yong Xu (Lexington, MA); Andrew F. Gardner (Manchester, MA); Daniel Heiter (Topsfield, MA); Pei-Chung Hsieh (Topsfield, MA); Rebecca Kucera (Hamilton, MA); Juan Pan (Beverly, MA)
Assignee: New England Biolabs, Inc.
C12N9/0069C12P19/34C12Q1/6846C12Y113/12007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,981,936
App. No.
18/478,512
Granted
May 14, 2024
Kind
B1
Abstract

The present disclosure relates, according to some embodiments, to telomere resolvases (e.g., TelA variants) having a turnover number over 1.

Claims (34)

1. A variant protelomerase capable of cleaving and rejoining a polynucleotide comprising a nucleotide sequence according to SEQ ID NO:16 and having a turnover number≥1.1, wherein the variant protelomerase comprises an amino acid sequence having at least 95% identity to SEQ ID NO:1 and having the following properties:

(a) X1 is T, M-T or M-H 8 -S-G-T;

(b) X97 is K or R;

(c) X98 is A; and

(d) X337 is G or G-H 6 ,

provided that if X1 is M-H 8 -S-G-T, X337 is G and if X337 is G-H 6 , X1 is T or M-T.

2. A variant protelomerase according to claim 1 , wherein the amino acid sequence further has the following additional properties:

(e) Y96 is Y;

(f) R100 is R;

(g) R101 is R; and

(h) K103 is K.

3. A variant protelomerase according to claim 1 , wherein the amino acid sequence has (a) X1 is M-T, (b) X97 is K or R, and (d) X337 is G.

4. A variant protelomerase according to claim 1 , wherein the amino acid sequence has (a) X1 is M-H 8 -S-G-T, (b) X97 is K or R, and (d) X337 is G.

5. A variant protelomerase according to claim 1 , wherein the amino acid sequence has (a) X1 is M-T, (b) X97 is K or R, and (d) X337 is G-H 6 .

6. A variant protelomerase according to claim 1 , wherein the amino acid sequence has at least 97% identity to SEQ ID NO:1.

7. A composition comprising:

a variant protelomerase according to claim 1 ; and

a buffer.

8. A composition according to claim 7 , wherein the buffer is a storage buffer or a reaction buffer.

9. A composition according to claim 7 further comprising a salt, a protein, a stabilizer, a detergent, a polyanion, a polynucleotide, a cell, a biological fluid or secretion, an aptamer, a pH indicator, a crowding agent, a sugar, a starch, cellulose, a glass-forming agent, a lipid, an oil, aqueous media, a support, or any combination thereof.

10. A composition according to claim 9 , wherein the salt comprises NaCl, MgCl 2 , MnCl 2 , CaCl 2 , an amino acid salt or any combination thereof.

11. A composition according to claim 9 , wherein the detergent is selected from an ionic detergent, a non-ionic detergent, and a zwitterionic detergent.

12. A composition according to claim 9 , wherein the polynucleotide is a variant TelA DNA substrate having a nucleotide sequence comprising at least one copy of SEQ ID NO:16.

13. A composition according to claim 7 further comprising propanediol, betaine, CaCl 2 , NaCl, KCl, potassium glutamate, poloxamer, octoxinol-9, polysorbate20, or combinations thereof.

14. A kit comprising:

a variant protelomerase according to claim 1 ; and

a buffer.

15. A kit according to claim 14 , wherein the buffer is a storage buffer or a reaction buffer.

16. A kit according to claim 14 further comprising a salt, a protein, a stabilizer, a detergent, a polyanion, a polynucleotide, a cell, a biological fluid or secretion, an aptamer, a pH indicator, a crowding agent, a sugar, a starch, cellulose, a glass-forming agent, a lipid, an oil, aqueous media, a support, or any combination thereof.

17. A kit according to claim 16 , wherein the salt comprises NaCl, MgCl 2 , MnCl 2 , CaCl 2 , an amino acid salt or any combination thereof.

18. A kit according to claim 16 , wherein the detergent is selected from an ionic detergent, a non-ionic detergent, and a zwitterionic detergent.

19. A kit according to claim 14 , wherein the variant protelomerase and the buffer are in separate containers.

20. A kit according to claim 16 , wherein the polynucleotide is an adapter.

21. A kit according to claim 16 , wherein the polynucleotide is a variant protelomerase DNA substrate having a nucleotide sequence comprising at least one copy of SEQ ID NO:16.

Assignments (2)
SECURITY INTEREST Recorded May 29, 2026
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 074795/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2023
From: XU, SHUANG-YONG; GARDNER, ANDREW F.; HEITER, DANIEL; HSIEH, PEI-CHUNG; KUCERA, REBECCA; PAN, JUAN
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 065148/0466 →